𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adoptive therapy of head and neck squamous cell carcinoma with antibody coated immune cells: a pilot clinical trial

✍ Scribed by Herbert Riechelmann; Markus Wiesneth; Peter Schauwecker; Peter Reinhardt; Silke Gronau; Anita Schmitt; Carsten Schroen; Judith Atz; Michael Schmitt


Publisher
Springer-Verlag
Year
2007
Tongue
English
Weight
488 KB
Volume
56
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Tumor lymphangiogenesis in head and neck
✍ Alessandro Franchi; Oreste Gallo; Daniela Massi; Gianna Baroni; Marco Santucci πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 159 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Tumor metastasis to regional lymph nodes via the lymphatic system represents the first step of dissemination in head and neck squamous cell carcinoma (HNSCC) and serves as a major prognostic indicator for disease progression and as a guide for therapeutic strategies. In t

Pilot trial of concomitant chemotherapy
✍ Olavo Feher; Sandro J. Martins; Candice A. Lima; JoΓ£o V. Salvajoli; Andrew J. Si πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 97 KB πŸ‘ 2 views

## Abstract ## Purpose The combination of chemotherapy and irradiation is considered the standard of care for the treatment of advanced squamous cell carcinoma of head and neck (SCCHN). Paclitaxel has shown a single‐agent activity in SCCHN. Besides, this drug is a promising radiosensitizer for som

Clinical utility of PET/CT in the evalua
✍ Luke Rudmik; Harold Y. Lau; T. Wayne Matthews; J. Douglas Bosch; Reinhard Kloibe πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 206 KB πŸ‘ 2 views

## Abstract ## Background Metastatic head and neck squamous cell carcinoma with an unknown primary is an uncommon but important problem. PET/CT, as an adjunct to diagnosis, is potentially useful but has never been studied in a prospective, single‐blinded clinical trial. ## Methods In all, 20 sub